Going Beyond the Molecule: The Multi-Factorial Causes of ARDS & COVID-19 ARDS as a Challenge for Drug Development

Time: 1:10 pm
day: Day Two


  • Reviewing the multiple elements that can lead to ARDS and COVID-ARDS, to better understand the targets to pursue to achieve therapeutic impact
  • Using the improving knowledge of COVID-19 ARDS to increase the number of pharmacological targets and therapeutic candidates for ARDS